Table 4.
Long-term outcomes.
| Groups | ||||
|---|---|---|---|---|
| 65–69 years | 70–74 years | ≥75 years | p-Value | |
| Creatinine levels (mg/dL) | ||||
| Preoperatively | 6.57 ± 1.86 | 6.03 ± 1.72 | 6.95 ± 3.32 | n.s. |
| 1-year | 1.99 ± 0.93 | 1.51 ± 0.46 | 1.79 ± 0.44 | 0.046 |
| 3-year | 1.93 ± 0.76 | 1.91 ± 0.72 | 2.05 ± 0.68 | n.s. |
| 5-year | 1.89 ± 0.83 | 1.82 ± 0.61 | 2.19 ± 1.13 | n.s. |
| Graft survival | ||||
| 1-year | 90.7% | 88.9% | 100% | n.s. |
| 3-year | 79.4% | 80.0% | 80.0% | n.s. |
| 5-year | 68.0% | 76.2% | 71.4% | n.s. |
| Patient survival | ||||
| 1-year | 92.9% | 85.7% | 100% | n.s. |
| 3-year | 79.4% | 77.8% | 72.7% | n.s. |
| 5-year | 68.0% | 61.5% | 62.5% | n.s. |
| Patient mortality at last follow-up |
11, 24% | 12, 42.9% | 6, 50% | |
| Of these: death with functioning graft |
8, 72.7% * | 7, 58.3% * | 4, 66.7% * | |
| Cause of death | ||||
| Cardiovascular | 2/4.4% | 0 | 0 | |
| Graft failure | 1/2.2% | 1/3.6% | 0 | |
| Infection/sepsis | 3/6.7% | 8/28.6% | 2/16.7% | |
| Malignancy | 4/8.9% | 1/3.6% | 2/16.7% | |
| Traumatic | 1/2.2% | 2/7.1% | 2/16.7% | |
All values with n (percent) or mean and (standard deviation, SD). p < 0.05, * Percentage is the result of n of patients with functioning graft divided by n of deceased patients at last follow-up; n.s = not significant.